What is OraVerse (a numbness reversal medication)?
OraVerse (phentolamine mesylate) accelerates the reversal of the lingering soft tissue numbness of the lip and tongue. Studies demonstrated that the average time to recovery of normal function was reduced by 60 minutes (50%) in the lower jaw and by 45 minutes (43%) in the upper jaw. The average time to recovery of normal tongue sensation was reduced by 65 minutes (52%) compared with control.
Who is a candidate for OraVerse?
OraVerse is recommended for adults, adolescents, and children aged 6 years and older weighing at least 33 lbs.
How is OraVerse given?
OraVerse is injected in the same amount and location as the original local anesthetic.
What are the disadvantages of OraVerse?
Across all studies, no known drug interactions or contraindications have been noted specific to OraVerse. All possible side effects reported in studies were the same as with local dental anesthetic. Those include heart irregularities, dizziness, and nausea. Temporary or permanent paresthesia, a change in sensation of the lip, chin, gums, and/or tongue, is also a risk when using dental anesthetics.
What is the cost of Oraverse?
This office offers Oraverse for $20 per treatment visit.